Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)
Public ClinicalTrials.gov record NCT01110902. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 8-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of Agomelatine 0.5 mg and 1 mg Sublingual Tablets Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study will assess efficacy, safety and tolerability of 0.5 mg/day and 1 mg/day of sublingual (under the tongue) formulation of agomelatine in patients with Major Depressive Disorder. This study includes an 8-week double-blind phase.
Study identification
- NCT ID
- NCT01110902
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 589 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2010 (Type not available)
- Primary completion
- Jun 2011 (Actual)
- Completion
- Jun 2011 (Actual)
- Last update posted
- Dec 24, 2020
2010 – 2011
United States locations
- U.S. sites
- 43
- U.S. states
- 22
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham, Department of Psychiatry | Birmingham | Alabama | 35294 | — |
| ATP Clinical Research | Costa Mesa | California | 92626 | — |
| Valley Clinical Research | El Centro | California | 92243 | — |
| Collaborative Neuroscience Network | Garden Grove | California | 92845 | — |
| University of California, Irvine Medical Center | Orange | California | 92868 | — |
| Anderson Clinical Research | Redlands | California | 92374 | — |
| Affiliated Research Institute | San Diego | California | 92108 | — |
| California Neuroscience Research Medical Group, Inc. | Sherman Oaks | California | 91403 | — |
| Viking Clinical Research | Temecula | California | 92591 | — |
| ICSL Clinical Studies | Altamonte Springs | Florida | 32701 | — |
| Florida Clinical Research Center, LLC | Bradenton | Florida | 34208 | — |
| Arocha Research Center | Coral Gables | Florida | 33134 | — |
| Innova Clinical Trials | Miami | Florida | 33145 | — |
| Miami Research Associates | South Miami | Florida | 33143 | — |
| Emory University | Atlanta | Georgia | 30306 | — |
| Alexian Brothers Center for Psychiatric Research | Hoffman Estates | Illinois | 60169 | — |
| Joliet Center for Clinical Research | Joliet | Illinois | 60435 | — |
| CNS Clinical Trials | Park Ridge | Illinois | 60068 | — |
| Deaconess Clinic | Evansville | Indiana | 47713 | — |
| Heartland Research Associates, LLC | Wichita | Kansas | 67207 | — |
| Pharmasite Research | Pikesville | Maryland | 21208 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Boston Clinical Trials | Brighton | Massachusetts | 02135 | — |
| Mercy Health Research | St Louis | Missouri | 63141 | — |
| Premier Psychiatry Group, LLC | Lincoln | Nebraska | 68510 | — |
| CRI Worldwide, LLC - Lourdes Division | Willingboro | New Jersey | 08046 | — |
| Social Psychiatric Research Institute | Brooklyn | New York | 11235 | — |
| Eastside Comprehensive Medical Service | New York | New York | 10021 | — |
| Neurobehavioral Clinical Research | Canton | Ohio | 44718 | — |
| University of Cincinnati Medical Center | Cincinnati | Ohio | 45219 | — |
| Neurology & Neuroscience Center of Ohio | Toledo | Ohio | 43623 | — |
| SP Research | Oklahoma City | Oklahoma | 73112 | — |
| Willamette Valley Clinical Studies | Eugene | Oregon | 97404 | — |
| Summit Research Network | Portland | Oregon | 97210 | — |
| CRI Worldwide, LLC - Kirkbride Division | Philadelphia | Pennsylvania | 19139 | — |
| Medical University of South Carolina | North Charleston | South Carolina | 29406 | — |
| CNS Healthcare | Memphis | Tennessee | 38119 | — |
| Research Strategies | Memphis | Tennessee | 38119 | — |
| FutureSearch Trials | Austin | Texas | 78731 | — |
| Claghorn-Lesem Research Clinic, Inc. | Houston | Texas | 77008 | — |
| University of Utah, Department of Psychiatry | Salt Lake City | Utah | 84132 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007 | — |
| Summit Research | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01110902, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 24, 2020 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01110902 live on ClinicalTrials.gov.